1-6 of 6
Dunnya De-Silva
Close
Sort by
Journal Articles

Fatigue, Quality of Life, and Physical Fitness Following an Exercise Intervention in Survivors of Multiple Myeloma: A Randomised Controlled Trial Using a Zelen Design

Joanne Sowter, MSc, Dimitrios A Koutoukidis, PhD, Maggie Heinrich, PhD, Orla McCourt, MSc, Allan Hackshaw, Rebecca Beeken, PhD, Dunnya De-Silva, Stephanie Philpott, MSc, Ali Rismani, MBBS, Neil K Rabin, MD, Rakesh Popat, MBBS, BSc, MRCP, FRCPath, PhD, Charalampia Kyriakou, MD PhD, Atul Mehta, FRCP, Bruce Paton, PhD, Abigail Fisher, PhD, Kwee Yong, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 974.
https://doi.org/10.1182/blood-2018-99-111403
Published: 2018
Journal Articles

Outcomes of Stratification to ASCT or Not Based on Depth of Response: Results of a Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Multiple Myeloma Patients with Deferred ASCT (PADIMAC)

Rakesh Popat, MD PhD, Ruth Mary De Tute, BSc,MSc, Nicholas Counsell, Dunnya De-Silva, Beth Phillips, MBBS, FRCPath, BSc, James D Cavenagh, Toyin Adedayo, Nivette Braganza, Claire Roddie, PhD MD, Mathew Streetly, Stephen Schey, MBBS, Mickey Koh, MD PhD, Josephine Crowe, Michael F. Quinn, FRCPath, MB, MD MRCP, Shirley D'Sa, MD FRCP, FRCPath, Andres E. Virchis, FRCP, FRCPath, Gordon Cook, PhD, Charles R Crawley, Guy Pratt, MD FRCP, FRCPath, Mark Cook, MBChB,PhD, Paul Smith, Laura Clifton-Hadley, PhDBSc, Neil Rabin, Roger G Owen, MD, Kwee Yong, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1864.
https://doi.org/10.1182/blood.V130.Suppl_1.1864.1864
Published: 2017
Journal Articles

Clinical Benefit of Depth of Response for Relapsed/Refractory Multiple Myeloma Patients Treated on Clinical Trials: Retrospective Analysis from Two Tertiary Centres

Hian Li Esther Chan, Dunnya De-Silva, Rakesh Popat, MD PhD, Neil Rabin, Ashu Wechalekar, Sufyan Achhala, Adeline Lin, Wee Joo Chng, MB ChB, MRCP, PhD, Kwee Yong, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1825.
https://doi.org/10.1182/blood.V130.Suppl_1.1825.1825
Published: 2017
Journal Articles

Duration of Therapy Is Independently Associated with Improved Progression Free and Overall Survival Following First Line Therapy for Non-Transplant Eligible Patients with Multiple Myeloma: Retrospective Analysis from a Single Centre

Dunnya De-Silva, MBBS, Adam Bloomfield, Nicholas Counsell, Simon Cheesman, BPharm, Ali Rismani, MBBS, Neil Rabin, Shirley D'Sa, Charalampia Kyriakou, Jayne Galinsky, Sarah Richard, Rakesh Popat, Atul Mehta, MD, Kwee L Yong
Journal: Blood
Blood (2016) 128 (22): 5684.
https://doi.org/10.1182/blood.V128.22.5684.5684
Published: 2016
Journal Articles

Physical and Psychological Factors Influencing Fatigue and Quality of Life in Multiple Myeloma Survivors: Preliminary Results from the Mascot Lifestyle Study

Malgorzata Heinrich, PhD, Joanne Land, BSc, Orla McCourt, MSc, Stephanie Philpott, MSc, Bruce Paton, PhD, Rebecca J Beeken, PhD, Lee Smith, PhD, Dunnya De-Silva, MBBS, Ali Rismani, MBBS, Shirley D'Sa, Anastasia Chew, MBBS, MRCP, FRCPATH, Atul Mehta, MD, Abigail Fisher, PhD, Allan Hackshaw, PhD, Kwee L Yong
Journal: Blood
Blood (2016) 128 (22): 4776.
https://doi.org/10.1182/blood.V128.22.4776.4776
Published: 2016
Journal Articles

Is Treatment with Bortezomib for Multiple Myeloma or Amyloidosis Associated with Cytomegalovirus Reactivation?

Isobel Ramsay, Dunnya De-silva, Sarah Worthington, Mark Coyne, Ashutosh Wechalekar, Paul D Griffiths
Journal: Blood
Blood (2015) 126 (23): 4259.
https://doi.org/10.1182/blood.V126.23.4259.4259
Published: 2015